Show simple item record

dc.contributor.authorAzmanova, Maria*
dc.contributor.authorPitto-Barry, Anaïs*
dc.contributor.authorBarry, Nicolas P.E.*
dc.date.accessioned2018-04-13T14:21:41Z
dc.date.available2018-04-13T14:21:41Z
dc.date.issued2018
dc.identifier.citationAzmanova M, Pitto-Barry A and Barry NPE (2018) Schizophrenia: synthetic strategies and recent advances in drug design. MedChemComm. 9(5): 759-782.en_US
dc.identifier.urihttp://hdl.handle.net/10454/15486
dc.descriptionYesen_US
dc.description.abstractSchizophrenia is a complex and unpredictable mental disorder which affects several domains of cognition and behaviour. It is a heterogeneous illness characterised by positive, negative, and cognitive symptoms, often accompanied by signs of depression. In this tutorial review, we discuss recent progress in understanding the target sites and mechanisms of action of second-generation antipsychotic drugs. Progress in identifying and defining target sites has been accelerated recently by advances in neuroscience, and newly developed agents that regulate signalling by the main excitatory neurotransmitters in the brain are surveyed. Examples of novel molecules for the treatment of schizophrenia in preclinical and clinical development and their industrial sponsors are highlighted.en_US
dc.description.sponsorshipThe Royal Society, The Academy of Medical Sciences, The Wellcome Trust, The Government Department of Business, Energy and Industrial Strategy and the British Heart Foundation, The University of Bradford.en_US
dc.language.isoenen_US
dc.rights(c) 2018 Royal Society of Chemistry. Full-text reproduced in accordance with the publisher's self-archiving policy.en_US
dc.subjectSchizophrenia; Drug designen_US
dc.titleSchizophrenia: synthetic strategies and recent advances in drug designen_US
dc.status.refereedYesen_US
dc.date.Accepted2018-03-09
dc.date.application2018-03-16
dc.typeArticleen_US
dc.type.versionAccepted Manuscripten_US
dc.identifier.doihttps://doi.org/10.1039/C7MD00448F


Item file(s)

Thumbnail
Name:
azmanova_et_al_2018.pdf
Size:
1.892Mb
Format:
PDF
Description:
Keep suppressed - has older cover ...
Thumbnail
Name:
azmanova_et_al_2018.pdf
Size:
2.103Mb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record